Inhibition of Porphyromonas gingivalis-induced periodontal bone loss by CXCR4 antagonist treatment

Molecular Oral Microbiology

Volumn 27, Issue 6, 2012, Pages 449-457

  Mcintosh, M L ^a,b   Hajishengallis, G ^c  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

AMD3100; Bone loss; CXCR4; Periodontitis; Porphyromonas gingivalis

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; PLERIXAFOR;

ALVEOLAR BONE LOSS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL VIRULENCE; CONTINUOUS INFUSION; CONTROLLED STUDY; MOUSE; NONHUMAN; OSMOTIC PUMP; PERIODONTITIS; PERIODONTIUM; PORPHYROMONAS GINGIVALIS; SURVIVAL RATE;

ALVEOLAR BONE LOSS; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; BACTEROIDACEAE INFECTIONS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HETEROCYCLIC COMPOUNDS; INFUSION PUMPS, IMPLANTABLE; MICE; MICE, INBRED BALB C; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CXCR4;

EID: 84869029797     PISSN: 20411006     EISSN: 20411014     Source Type: Journal    
DOI: 10.1111/j.2041-1014.2012.00657.x     Document Type: Article

References (48)

1. Assuma, R., Oates, T., Cochran, D. et al. (1998) IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol160: 403-409.
2. Baker, P.J., Dixon, M. and Roopenian, D.C. (2000) Genetic control of susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect Immun68: 5864-5868.
3. Chaves, E.S., Jeffcoat, M.K., Ryerson, C.C. and Snyder, B. (2000) Persistent bacterial colonization of Porphyromonas gingivalis, Prevotella intermedia, and Actinobacillus actinomycetemcomitans in periodontitis and its association with alveolar bone loss after 6months of therapy. J Clin Periodontol27: 897-903.
4. Darveau, R.P. (2010) Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol8: 481-490.
5. De Clercq, E. (2005) Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100. Mini Rev Med Chem5: 805-824.
6. Donzella, G.A., Schols, D., Lin, S.W. et al. (1998) AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat Med4: 72-77.
7. Doungudomdacha, S., Rawlinson, A. and Douglas, C.W. (2000) Enumeration of Porphyromonas gingivalis, Prevotella intermedia and Actinobacillus actinomycetemcomitans in subgingival plaque samples by a quantitative-competitive PCR method. J Med Microbiol49: 861-874.
8. Eskan, M.A., Jotwani, R., Abe, T. et al. (2012) The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat Immunol13: 465-473.
9. Finlay, B.B. and McFadden, G. (2006) Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell124: 767-782.
10. Genco, R.J. and Van Dyke, T.E. (2010) Prevention: reducing the risk of CVD in patients with periodontitis. Nat Rev Cardiol7: 479-480.
11. Hajishengallis, G. (2009) Toll gates to periodontal host modulation and vaccine therapy. Periodontol 200051: 181-207.
12. Hajishengallis, G. (2010) Too old to fight? Aging and its toll on innate immunity. Mol Oral Microbiol25: 25-37.
13. Hajishengallis, G. and Harokopakis, E. (2007) Porphyromonas gingivalis interactions with complement receptor 3 (CR3): innate immunity or immune evasion?Front Biosci12: 4547-4557.
14. Hajishengallis, G. and Lambris, J.D. (2011) Microbial manipulation of receptor crosstalk in innate immunity. Nat Rev Immunol11: 187-200.
15. Hajishengallis, G., Tapping, R.I., Harokopakis, E. et al. (2006) Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus. Cell Microbiol8: 1557-1570.
16. Hajishengallis, G., Wang, M., Liang, S. et al. (2008) Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. Proc Natl Acad Sci U S A105: 13532-13537.
17. Hajishengallis, G., Liang, S., Payne, M.A. et al. (2011) Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe10: 497-506.
18. Hasturk, H., Kantarci, A., Goguet-Surmenian, E. et al. (2007) Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol179: 7021-7029.
19. Hatse, S., Princen, K., Bridger, G. et al. (2002) Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett527: 255-262.
20. Hendrix, C.W., Flexner, C., MacFarland, R.T. et al. (2000) Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother44: 1667-1673.
21. Hirbe, A.C., Rubin, J., Uluckan, O. et al. (2007) Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone. Proc Natl Acad Sci U S A104: 14062-14067.
22. Hogaboam, C.M., Carpenter, K.J., Schuh, J.M. et al. (2005) The therapeutic potential in targeting CCR5 and CXCR4 receptors in infectious and allergic pulmonary disease. Pharmacol Ther107: 314-328.
23. Jotwani, R., Muthukuru, M. and Cutler, C.W. (2004) Increase in HIV receptors/co-receptors/alpha-defensins in inflamed human gingiva. J Dent Res83: 371-377.
24. Kato, T., Kawai, S., Nakano, K. et al. (2007) Virulence of Porphyromonas gingivalis is altered by substitution of fimbria gene with different genotype. Cell Microbiol9: 753-765.
25. Kebschull, M., Demmer, R., Behle, J.H. et al. (2008) Granulocyte chemotactic protein 2 (gcp-2/cxcl6) complements interleukin-8 in periodontal disease. J Periodont Res44: 465-471.
26. Kornman, K.S. (2006) Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. Am J Clin Nut83: 475S-483S.
27. Kuboniwa, M., Amano, A., Kimura, K.R. et al. (2004) Quantitative detection of periodontal pathogens using real-time polymerase chain reaction with TaqMan probes. Oral Microbiol Immunol19: 168-176.
28. Kumar, P.S., Leys, E.J., Bryk, J.M. et al. (2006) Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. J Clin Microbiol44: 3665-3673.
29. Lalla, E. and Papapanou, P.N. (2011) Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat Rev Endocrinol7: 738-748.
30. Lee, H.M., Wysoczynski, M., Liu, R. et al. (2009) Mobilization studies in complement-deficient mice reveal that optimal AMD3100 mobilization of hematopoietic stem cells depends on complement cascade activation by AMD3100-stimulated granulocytes. Leukemia24: 573-582.
31. Liang, S., Krauss, J.L., Domon, H. et al. (2011) The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J Immunol186: 869-877.
32. Lukacs, N.W., Berlin, A., Schols, D. et al. (2002) AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. Am J Pathol160: 1353-1360.
33. Lundberg, K., Wegner, N., Yucel-Lindberg, T. and Venables, P.J. (2010) Periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol6: 727-730.
34. Matthys, P., Hatse, S., Vermeire, K. et al. (2001) AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-γ receptor-deficient mice. J Immunol167: 4686-4692.
35. Moore, W.E., Holdeman, L.V., Smibert, R.M. et al. (1982) Bacteriology of severe periodontitis in young adult humans. Infect Immun38: 1137-1148.
36. Moore, W.E., Moore, L.H., Ranney, R.R. et al. (1991) The microflora of periodontal sites showing active destructive progression. J Clin Periodontol18: 729-739.
37. Naito, M., Hirakawa, H., Yamashita, A. et al. (2008) Determination of the genome sequence of Porphyromonas gingivalis strain ATCC 33277 and genomic comparison with strain W83 revealed extensive genome rearrangements in P. gingivalis. DNA Res15: 215-225.
38. Oberlin, E., Amara, A., Bachelerie, F. et al. (1996) The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature382: 833-835.
39. Pasare, C. and Medzhitov, R. (2005) Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol560: 11-18.
40. Pierce, D.L., Nishiyama, S., Liang, S. et al. (2009) Host adhesive activities and virulence of novel fimbrial proteins of Porphyromonas gingivalis. Infect Immun77: 3294-3301.
41. Pihlstrom, B.L., Michalowicz, B.S. and Johnson, N.W. (2005) Periodontal diseases. Lancet366: 1809-1820.
42. Pusic, I. and DiPersio, J.F. (2010) Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells. Curr Opin Hematol17: 319-326.
43. Schols, D. (2004) HIV co-receptors as targets for antiviral therapy. Curr Top Med Chem4: 883-893.
44. Tonetti, M.S., D'Aiuto, F., Nibali, L. et al. (2007) Treatment of periodontitis and endothelial function. N Engl J Med356: 911-920.
45. Triantafilou, K., Triantafilou, M. and Dedrick, R.L. (2001) A CD14-independent LPS receptor cluster. Nat Immunol2: 338-345.
46. Wang, M., Shakhatreh, M.A., James, D. et al. (2007) Fimbrial proteins of Porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages. J Immunol179: 2349-2358.
47. Wang, M., Krauss, J.L., Domon, H. et al. (2010) Microbial hijacking of complement-toll-like receptor crosstalk. Sci Signal3: ra11.
48. Wright, L.M., Maloney, W., Yu, X. et al. (2005) Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. Bone36: 840-853.